Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Enanta Pharmaceuticals (ENTA) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 32 quarters since 2013. Compare with ENTA stock chart to see long term trends.

ENTA Stock Compared to Quarterly

ENTA Income Statement

Revenue, Net:23575000
Revenue Per Share:1.17
Research & Development Expense:48946000
Total Operating Expenses:57302000
Operating Income:-33727000
Income Taxes:-8795000
Net Income:-24599000
Earnings Per Share, Basic:-1.23
Shares Outstanding, Basic Avg:20171000

ENTA Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:806000
Change in Accounts Receiveable:1952000
Net Cash from Operations:-21021000
Net Cash from Financing Activities:943000
Property, Plant & Equipment Purchases:33000
Net Cash from Investing Activities:72683000
Net Change in Cash & Equivalents:52605000

ENTA Balance Sheet

Cash and Cash Equivalents:57814000
Accounts Receivable, Net:23576000
Total Current Assets:319021000
Property, Plant & Equipment, Net:5943000
Total Assets:438791000
Accounts Payable:9540000
Total Short-Term Liabilities:36172000
Total Liabilities:39362000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
3,595,053 sh
-76,953 sh
-2%
$204,237
$42,631
Farallon Capital Management LLC
1,995,000 sh
 
$113,336
Armistice Capital, LLC
1,836,000 sh
-164,000 sh
-8%
$104,303
$16,283
Vanguard Group Inc
1,800,363 sh
-56,656 sh
-3%
$102,278
$20,551
State Street Corp
1,072,182 sh
18,107 sh
2%
$60,911
$14,521
First Manhattan Co
969,736 sh
936,536 sh
2821%
$55,090
$53,629
Northern Trust Corp
959,048 sh
310,246 sh
48%
$54,483
$25,929
Krensavage Asset Management, LLC
936,777 sh
-2,873 sh
0%
$53,218
$11,864
Renaissance Technologies LLC
756,585 sh
-41,143 sh
-5%
$42,982
$7,874
Dimensional Fund Advisors LP
610,866 sh
-33,922 sh
-5%
$34,703
$6,326
Geode Capital Management, LLC
333,793 sh
3,384 sh
1%
$18,962
$4,421
Fairmount Funds Management LLC
316,952 sh
138,894 sh
78%
$18,006
$10,170
Price T Rowe Associates Inc /Md/
262,123 sh
9,341 sh
4%
$14,891
$3,766
Jacobs Levy Equity Management, Inc
253,814 sh
-5,739 sh
-2%
$14,419
$2,996
Acadian Asset Management LLC
238,640 sh
-128,372 sh
-35%
$13,536
-$2,619
Bank Of New York Mellon Corp
183,342 sh
6,969 sh
4%
$10,416
$2,655
Granahan Investment Management Inc/Ma
182,816 sh
-17,154 sh
-9%
$10,386
$1,585
Soleus Capital Management, L.P.
182,400 sh
182,400 sh
NEW
$10,362
$10,362
Morgan Stanley
162,232 sh
-13,975 sh
-8%
$9,217
$1,461
Charles Schwab Investment Management Inc
127,746 sh
1,015 sh
1%
$7,258
$1,680

Data imported from Enanta Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.